Volver a Agenda
Session 1: Patients are waiting: Health Authority regulators, WHO and Industry approaches to accelerate patients’ access to innovation
Session Chair(s)
Catherine Al Ashram
VP Regulatory Affairs & PV, Latin America MEA and Russia
Organon, Jordan
Jeffrey Kemprecos
CGA Director-Gulf
Glaxosmithkline, United Arab Emirates
Session 1: Patients are waiting: Health Authority Regulators, WHO and Industry approaches to accelerate patients’ access to innovation
Speaker(s)
Putting Reliance into Practice: WHO’s Activities on Regulatory Systems Strengthening
Samvel Azatyan, MD, PhD
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Senior Adviser
The ICH perspective
Lenita Lindström, LLM
European Commission, Belgium
ICH Assembly Chair and Senior Expert, European Commission
Access to Innovative Medicines: Study Comparing Regulatory Timelines in 10 Countries in the Middle East & Africa
Mohamed Omar
IQVIA, Egypt
Associate Director
The Reliance Model Implementation in Practice: Examples from Jordan, Saudi Arabia and Egypt - Introduction
Inas Chehimi
Novartis Pharma Services AG, United Arab Emirates
Head Regulatory Affairs - Middle East & North Africa
The Reliance Model Implementation in Practice: Example from Egypt
Heba Nabil
Pfizer, Egypt
Chair-Egypt RWG EFPR & Regulatory Sciences Director- Egypt & Sudan
The Reliance Model Implementation in Practice: Example from Jordan
Wesal Al Haqish
Jordan Food and Drug Administration (JFDA), Jordan
Drug Directorate Director
The Reliance Model Implementation in Practice: Example from Saudi Arabia
Bandar Al Hammad, MPharm
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Chief Pharmacist & Director of Veterinary Preparations Department
¿Tiene una cuenta?